Dr. Memarzadeh on Recurrence Rates in Ovarian Cancer

October 13, 2015
Sanaz Memarzadeh, MD, PhD
Sanaz Memarzadeh, MD, PhD

Partner | Cancer Centers | <b>UCLA Jonsson Comprehensive Cancer Center</b>

Sanaz Memarzadeh, MD, PhD, gynecologic oncology, obstetrics and gynecology, University of California, Los Angeles, discusses recurrence rates in ovarian cancer.

Sanaz Memarzadeh, MD, PhD, gynecologic oncology, obstetrics and gynecology, University of California, Los Angeles, discusses recurrence rates in ovarian cancer.

The challenge with epithelial ovarian cancer, Memarzadeh says, is that the majority of patients present with advanced disease due to lack of identified biomarkers and little to no symptoms.

Therefore, in patients with stage III to IV epithelial ovarian cancer, approximately 80% to 85% relapse, despite undergoing surgeries and/or chemotherapy.


x